Enolase
From Proteopedia
(Difference between revisions)
Line 28: | Line 28: | ||
Enolase is present in all tissues and organisms with the ability to do glycolysis or fermentation. Recent studies have Enolase concentration samples in order to determine certain conditions and their severity. For instance, high concentrations of Enolase in cerebrospinal fluid (CSF) are more strongly associated with astrocytoma than other enzymes like aldolase, pyruvate kinase, and creatine kinase. High concentrations of Enolase in the CSF are also linked to the fastest rate of tumor growth and increased chances of heart attack or stroke. | Enolase is present in all tissues and organisms with the ability to do glycolysis or fermentation. Recent studies have Enolase concentration samples in order to determine certain conditions and their severity. For instance, high concentrations of Enolase in cerebrospinal fluid (CSF) are more strongly associated with astrocytoma than other enzymes like aldolase, pyruvate kinase, and creatine kinase. High concentrations of Enolase in the CSF are also linked to the fastest rate of tumor growth and increased chances of heart attack or stroke. | ||
Enolase can be competitively inhibited by fluoride for the substrate 2-PGA. In drinking water with added fluorination, oral bacteria Enolase activity is inhibited without harmed humans. This works to prevent cavities. | Enolase can be competitively inhibited by fluoride for the substrate 2-PGA. In drinking water with added fluorination, oral bacteria Enolase activity is inhibited without harmed humans. This works to prevent cavities. | ||
- | </StructureSection> | + | |
+ | ==3D structures of enolase== | ||
+ | [[Enolase 3D structures]] | ||
+ | |||
+ | </StructureSection> | ||
==3D structures of enolase== | ==3D structures of enolase== | ||
Line 64: | Line 68: | ||
**[[4z17]] - CaENO + PEP <br /> | **[[4z17]] - CaENO + PEP <br /> | ||
**[[4z1y]] - CaENO + 2PGA<br /> | **[[4z1y]] - CaENO + 2PGA<br /> | ||
+ | **[[6j36]] - ENO – ''Mycoplasma hyopneumaniae''<br /> | ||
+ | **[[6nb2]] – LpENO + 2PGA – ''Legionella pneumophila''<br /> | ||
+ | **[[6nbm]] - LpENO + phosphate <br /> | ||
+ | **[[6o4n]] - ENO + phosphate – ''Chladmydia trachomatis'' <br /> | ||
*Enolase 1 | *Enolase 1 | ||
Line 72: | Line 80: | ||
**[[1e9i]] - EcENO1 – ''Escherichia coli''<BR /> | **[[1e9i]] - EcENO1 – ''Escherichia coli''<BR /> | ||
**[[2xgz]], [[2xh0]], [[2xh2]], [[2xh4]], [[2xh7]] – EcENO1 residues 2-437 (mutant) <BR /> | **[[2xgz]], [[2xh0]], [[2xh2]], [[2xh4]], [[2xh7]] – EcENO1 residues 2-437 (mutant) <BR /> | ||
- | **[[ | + | **[[6bfy]] - EcENO1 + 2PGA<br /> |
+ | **[[6bfz]] - EcENO1 + PEP<br /> | ||
**[[3h8a]], [[2fym]], [[5ohg]] – EcENO1 + RNase E<BR /> | **[[3h8a]], [[2fym]], [[5ohg]] – EcENO1 + RNase E<BR /> | ||
+ | **[[3uj2]] – ENO1 – ''Anaerostipes caccae''<br /> | ||
**[[3enl]], [[4enl]] – yENO1 - yeast<BR /> | **[[3enl]], [[4enl]] – yENO1 - yeast<BR /> | ||
**[[2al1]], [[2al2]], [[1ebh]] – yENO1 + Mg<BR /> | **[[2al1]], [[2al2]], [[1ebh]] – yENO1 + Mg<BR /> | ||
Line 79: | Line 89: | ||
**[[1ebg]], [[1els]] - yENO1 + PAH<BR /> | **[[1ebg]], [[1els]] - yENO1 + PAH<BR /> | ||
**[[1l8p]] - yENO1 (mutant) + PAH<BR /> | **[[1l8p]] - yENO1 (mutant) + PAH<BR /> | ||
- | **[[2one]], [[1one]] – yENO1 + PEP + | + | **[[2one]], [[1one]] – yENO1 + PEP + 2PGA<BR /> |
- | **[[5enl]], [[7enl]] - yENO1 + | + | **[[5enl]], [[7enl]] - yENO1 + 2PGA<BR /> |
**[[1nel]], [[6enl]] – yENO1 + inhibitor | **[[1nel]], [[6enl]] – yENO1 + inhibitor | ||
Line 94: | Line 104: | ||
*γ Enolase (neuron specific enolase) | *γ Enolase (neuron specific enolase) | ||
- | **[[1te6]], [[3ucc]], [[3ucd]], [[3uje]], [[3ujf]], [[3ujr]], [[3ujs]] – hENOγ<BR /> | + | **[[1te6]], [[3ucc]], [[3ucd]], [[3uje]], [[3ujf]], [[3ujr]], [[3ujs]], [[5td9]] – hENOγ<BR /> |
- | **[[2akm]], [[2akz]], [[5eu9]], [[5idz]], [[4za0]], [[4zcw]] – hENOγ + inhibitor<br /> | + | **[[2akm]], [[2akz]], [[5eu9]], [[5idz]], [[4za0]], [[4zcw]], [[5tij]] – hENOγ + inhibitor<br /> |
*2, 3-diketo-5-methylthiopentyl-1-phosphate enolase | *2, 3-diketo-5-methylthiopentyl-1-phosphate enolase |
Revision as of 07:52, 20 June 2019
|
3D structures of enolase
Updated on 20-June-2019
Additional Resources
For additional information, see: Carbohydrate Metabolism
References
- ↑ Voet, Donald, Judith G. Voet, and Charlotte W. Pratt. Fundamentals of Biochemistry: Life at the Molecular Level. 3rd ed. Hoboken, NJ: John Wiley & Sons, Inc., 2008.
- ↑ Voet, Donald, Judith G. Voet, and Charlotte W. Pratt. Fundamentals of Biochemistry: Life at the Molecular Level. 3rd ed. Hoboken, NJ: John Wiley & Sons, Inc., 2008.
- ↑ Pancholi, V. "Multifunctional a-Enolase: Its Role in Diseases." CMLS, Cellular and Molecular Life Sciences 58 (2001): 902-20.
- ↑ The scop authors. Structural Classification of Proteins. “Protein: Enolase from Baker's yeast (Saccharomyces cerevisiae). 2009. 2/26 2010. [<http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.b.bc.b.b.html>.]
- ↑ The scop authors. Structural Classification of Proteins. “Protein: Enolase from Baker's yeast (Saccharomyces cerevisiae). 2009. 2/26 2010. [<http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.b.bc.b.b.html>.]
- ↑ Nguyen, Tram, and Katelyn Thompson. "Mechanism of Enolase Converting 2-Phosphoglycerate to Phosphoenolpyruvate." ChemDraw 10.0: Public Domain, 2008. [1].
- ↑ Voet, Donald, Judith G. Voet, and Charlotte W. Pratt. Fundamentals of Biochemistry: Life at the Molecular Level. 3rd ed. Hoboken, NJ: John Wiley & Sons, Inc., 2008.
- ↑ Westhead, E. W., and BO G. Malmstrom. "The Chemical Kinetics of the Enolase Reaction with Special References to the Use of Mixed Solvents." The Journal of Biological Chemistry 228 (1957): 655-71.
- ↑ Westhead, E. W., and BO G. Malmstrom. "The Chemical Kinetics of the Enolase Reaction with Special References to the Use of Mixed Solvents." The Journal of Biological Chemistry 228 (1957): 655-71.
- ↑ Pancholi, V. "Multifunctional a-Enolase: Its Role in Diseases." CMLS, Cellular and Molecular Life Sciences 58 (2001): 902-20.
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, David Canner, Alexander Berchansky, Jaime Prilusky, Cory Tiedeman, Joel L. Sussman